$39.06
▼ -3.5% Today
as of Aug 5, 16:53 ET
Last 30 days
Recent Press Releases & News
Rigel Pharmaceuticals Q2 Earnings Call Highlights
Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates
Rigel: Q2 Earnings Snapshot
Overview
52-week range
$18
$52
61% of range
Avg surprise (last 3)
+125.3%
Avg reaction (last 2)
-4.7%
0% positive
Latest IV / EM
73%
EM ±12.2% · $40 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $0.44 | $0.74 | -40.5% | -30.2% | -4.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $1.46 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $3.28 | $1.97 | +66.5% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.63 | $0.14 | +350.0% | — | -4.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.70 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.06 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.47 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.33 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.38 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $59M | — | $69M | $102M | $53M | — | $55M | $37M |
| Cost of revenue | $5M | — | $5M | $5M | $4M | — | $8M | $3M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $12M | — | $28M | $61M | $13M | — | $14M | $447,000 |
| Net income | $9M | — | $28M | $60M | $11M | — | $12M | $-1M |
| EPS (diluted) | $0.44 | — | $1.46 | $3.28 | $0.63 | — | $0.70 | $-0.06 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $24M | $41M | $49M | $53M | $46M | $57M | $52M | $36M |
| Inventory | $12M | $12M | $13M | $10M | $5M | $6M | $5M | $8M |
| Total current assets | $234M | $240M | $215M | $175M | $147M | $135M | $106M | $95M |
| Total assets | $505M | $514M | $243M | $207M | $176M | $164M | $139M | $128M |
| Long-term debt | $45M | — | $60M | $60M | $60M | — | $60M | $60M |
| Total liabilities | $105M | $122M | $125M | $125M | $157M | $161M | $154M | $158M |
| Total equity | $400M | $391M | $118M | $82M | $19M | $3M | $-15M | $-30M |